Optimizing care for gastric cancer with overt bleeding:Is systemic therapy a valid option?  

作　　者：Emad Qayed 

机构地区：[1]Department of Medicine,Division of Digestive Diseases,Emory University School of Medicine,Atlanta,GA 30303,United States

出　　处：《World Journal of Clinical Oncology》2025年第1期1-4,共4页世界临床肿瘤学杂志（英文）

摘　　要：Gastric cancer(GC)and gastroesophageal junction cancer(GEJC)represent a significant burden globally,with complications such as overt bleeding(OB)further exacerbating patient outcomes.A recent study by Yao et al evaluated the effectiveness and safety of systematic treatment in GC/GEJC patients presenting with OB.Using propensity score matching,the study balanced the comparison groups to investigate overall survival and treatment-related adverse events.The study's findings emphasize that systematic therapy can be safe and effective and contribute to the ongoing debate about the management of advanced GC/GEJC with OB,highlighting the complexities of treatment decisions in these high-risk patients.

关 键 词：Gastric cancer Overt bleeding Systemic therapy Endoscopic therapy HEMOSTASIS 

分 类 号：R473.73[医药卫生—护理学]